← 返回

酸性 pH 可通过穿孔素失活削弱免疫杀伤

英文原题:Acidic pH can attenuate immune killing through inactivation of perforin.

查看英文原题

Acidic pH can attenuate immune killing through inactivation of perforin.

PubMed 2025/01/09(内容时间) EMBO Rep Q1 · IF 6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

细胞毒性淋巴细胞对我们的免疫系统至关重要,主要通过穿孔素/颗粒酶杀伤机制清除病毒感染细胞或癌细胞。穿孔素在质膜上形成跨膜孔,使颗粒酶进入靶细胞胞质并触发凋亡。细胞毒性淋巴细胞高效清除靶细胞的能力已被广泛用于针对血液系统癌症的免疫治疗中。尽管努力在实体瘤中实现类似效果,但免疫抑制性和酸性肿瘤微环境构成了持续障碍。利用不同类型的效应细胞,包括治疗相关的抗CD19 CAR-T 细胞,我们证明实体瘤中常见的酸性pH通过阻碍免疫突触内穿孔素孔的形成,削弱了免疫疗法的效力。对纯化重组穿孔素进行寡聚化的纳米尺度研究表明,孔形成被特异性抑制,原因是阻止了跨膜β-桶结构的形成。穿孔素孔形成的缺失直接阻止了靶细胞死亡。这一发现揭示了免疫效应抑制的新层面,在开发针对实体瘤的有效免疫疗法时必须予以考虑。

展开英文摘要原文

Cytotoxic lymphocytes are crucial to our immune system, primarily eliminating virus-infected or cancerous cells via perforin/granzyme killing. Perforin forms transmembrane pores in the plasma membrane, allowing granzymes to enter the target cell cytosol and trigger apoptosis. The prowess of cytotoxic lymphocytes to efficiently eradicate target cells has been widely harnessed in immunotherapies against haematological cancers. Despite efforts to achieve a similar outcome against solid tumours, the immunosuppressive and acidic tumour microenvironment poses a persistent obstacle.

Using different types of effector cells, including therapeutically relevant anti-CD19 CAR T cells, we demonstrate that the acidic pH typically found in solid tumours hinders the efficacy of immune therapies by impeding perforin pore formation within the immunological synapse.

A nanometre-scale study of purified recombinant perforin undergoing oligomerization reveals that pore formation is inhibited specifically by preventing the formation of a transmembrane -barrel. The absence of perforin pore formation directly prevents target cell death. This finding uncovers a novel layer of immune effector inhibition that must be considered in the development of effective immunotherapies for solid tumours.

论文信息

作者
Hodel AW、Rudd-Schmidt JA、Noori T、Lupton CJ、Cheuk VCT、Trapani JA、Hoogenboom BW、Voskoboinik I
第一作者单位
Killer Cell Biology Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. adrian.hodel@petermac.org.Australia
通讯作者单位
Killer Cell Biology Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. ilia.voskoboinik@petermac.org.Australia
期刊
EMBO reports2025 Feb
原文标识
PubMed 39789387 · DOI 10.1038/s44319-024-00365-6